HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 21, 14711-14718, May 26, 2006

This Article Full Text Full Text (PDF) All Versions of this Article: 281/21/14711    most recent M513810200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, N. Articles by Zhou, M. Search for Related Content PubMed PubMed Citation Articles by Zhu, N. Articles by Zhou, M. Social Bookmarking                      What's this?

KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia^*

Ningxi Zhu¹, Lubing Gu¹, Harry W. Findley, Ceshi Chen, Jin-Tang Dong, Lily Yang^¶, and Muxiang Zhou²

From the The Division of Pediatric Hematology/Oncology, Winship Cancer Institute and Department of Hematology/Oncology, ^¶Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322

The Kruppel-like factor 5 (KLF5) is a transcription factor that regulates cellular signaling involved in cell proliferation and oncogenesis. Here, we report that KLF5 interacts with tumor suppressor p53 in regulating the expression of the inhibitor-of-apoptosis protein survivin, which may play a role in pathological process of cancer. The core promoter region of survivin contains multiple GT-boxes that have been characterized as KLF5 response elements. Deletion and mutation analyses as well as chromatin immunoprecipitation and electronic mobility shift assay indicated that KLF5 binds to the core survivin promoter and strongly induces its activity. Furthermore, we demonstrated that KLF5 protein is able to bind to p53 and abrogate the p53-regulated repression of survivin. Transfection of KLF5 into a KLF5-negative acute lymphoblastic leukemia cell line EU-8 enhanced survivin expression, and conversely, silencing of KLF5 by small interfering RNA in a KLF5-overexpressing acute lymphoblastic leukemia cell line EU-4 down-regulated survivin expression. The KLF5 small interfering RNA-mediated down-regulation of survivin sensitized EU-4 cells to apoptosis induced by chemotherapeutic drug doxorubicin. These findings identify a novel regulatory pathway for the expression of survivin under the control of KLF5 and p53. Deregulation of this pathway may result in overexpression of survivin in cancer, thus contributing to drug resistance.

Received for publication, December 27, 2005 , and in revised form, March 30, 2006.

^* This work was supported by National Institutes of Health Grant R01 CA82323, The Leukemia and Lymphoma Society Grant 6249-05, and by the Children's Leukemia Research Association Inc. and CURE Childhood Cancer Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ These authors contributed equally to this work.

² To whom correspondence should be addressed: Division of Pediatric Hematology/Oncology, Emory University School of Medicine, 2015 Uppergate Dr., Atlanta, GA 30322. Tel.: 404-727-1426; Fax: 404-727-4455; E-mail: mzhou{at}emory.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Liu, H.-Q. Zheng, Z. Zhou, J.-T. Dong, and C. Chen KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization J. Biol. Chem., June 19, 2009; 284(25): 16791 - 16798. [Abstract] [Full Text] [PDF]

				D. Raj, T. Liu, G. Samadashwily, F. Li, and D. Grossman Survivin repression by p53, Rb and E2F2 in normal human melanocytes Carcinogenesis, January 1, 2008; 29(1): 194 - 201. [Abstract] [Full Text] [PDF]

				K. H. Vousden Outcomes of p53 activation - spoilt for choice J. Cell Sci., December 15, 2006; 119(24): 5015 - 5020. [Abstract] [Full Text] [PDF]